Insider · CIK 0001445826
David R Epstein
Files at TEM (Tempus AI, Inc.), AGMB (AgomAb Therapeutics NV). First filing Dec 13, 2024, latest Oct 9, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
TEM: Tempus AI, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
AGMB: AgomAb Therapeutics NV
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | AgomAb Therapeutics NV | $45k 5,000 shares | +50% | - | |
| 47Moderate | AgomAb Therapeutics NV | $86k 10,000 shares | - | - | |
| 10Weak | Tempus AI, Inc. | $16k 250 shares | -1% | +50% from low-40% from high | |
| 10Weak | Tempus AI, Inc. | $18k 250 shares | -1% | +146% from low-12% from high | |
| 0Weak | Tempus AI, Inc. | $20k 370 shares | -1% | +72% from low-39% from high | |
| 10Weak | Tempus AI, Inc. | $14k 250 shares | -1% | +99% from low-29% from high | |
| 10Weak | Tempus AI, Inc. | $20k 370 shares | -1% | +63% from low-42% from high | |
| 16Weak | Tempus AI, Inc. | $46k 990 shares | -4% | +57% from low-44% from high | |
| 10Weak | Tempus AI, Inc. | $14k 250 shares | -1% | - | |
| 10Weak | Tempus AI, Inc. | $20k 370 shares | -1% | - | |
| 15Weak | Tempus AI, Inc. | $26k 620 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | AGMB AgomAb Therapeutics NV | POpen-market purchase Common shares | +5,000 | $8.90 | $45k | 15,000 | 3 d ago |
| Oct 5, 2026 | AGMB AgomAb Therapeutics NV | POpen-market purchase Common shares | +5,000 | $8.57 | $43k | 5,000 | 5 d ago |
| Oct 6, 2026 | AGMB AgomAb Therapeutics NV | POpen-market purchase Common shares | +5,000 | $8.70 | $44k | 10,000 | 5 d ago |
| Sep 1, 2026 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -250 | $65.55 | $16k | 30,844 | 39 d ago |
| Sep 2, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Comnmon Stock10b5-1 | -250 | $73.64 | $18k | 27,041 | Sep 4, 2025 |
| Aug 1, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Comnmon Stock10b5-1 | -370 | $55.16 | $20k | 27,291 | Aug 5, 2025 |
| Jun 2, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Comnmon Stock10b5-1 | -250 | $55.20 | $14k | 27,661 | Jun 4, 2025 |
| May 20, 2025 | TEM Tempus AI, Inc. | AGrant or award Class A Comnmon Stock | +1,997 | $0.00 | $0 | 27,911 | May 22, 2025 |
| May 1, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -370 | $53.50 | $20k | 25,914 | May 5, 2025 |
| Mar 17, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -990 | $46.83 | $46k | 26,284 | Mar 19, 2025 |
| Mar 3, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -250 | $57.52 | $14k | 27,274 | Mar 5, 2025 |
| Feb 3, 2025 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -370 | $53.31 | $20k | 27,524 | Feb 5, 2025 |
| Dec 11, 2024 | TEM Tempus AI, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -620 | $41.81 | $26k | 27,894 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.